Hawthorne generics company accused of patent infringement
A Hawthorne pharmaceutical company that has applied for federal approval to produce a generic insomnia drug has been sued for patent infringement. Currax Pharmaceuticals accused Taro Pharmaceuticals U.S.A. Inc. of ten counts of patent infringement, in a …